[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Immune Checkpoint Inhibitors Sales Market Report 2018

February 2018 | 111 pages | ID: G7E5C33607AEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Immune Checkpoint Inhibitors market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Immune Checkpoint Inhibitors for these regions, from 2013 to 2025 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Immune Checkpoint Inhibitors market competition by top manufacturers/players, with Immune Checkpoint Inhibitors sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Bristol Myer Squibb
  • AstraZeneca
  • Merck & Co.
  • Roche / Genentech
  • Incyte Corporation
  • NewLink Genetics
  • ArGEN-X
  • Seattle Genetics
  • Pfizer
  • MacroGenics
  • Celldex Therapeutics
  • CureTech
  • Immutep
  • Innate Pharma
  • Sorrento Therapeutics
  • GlaxoSmithKline
  • GITR, Inc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • PD-1/PD-L1
  • CTLA-4
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Lung Cancer
  • Colorectal Cancer
  • Breast Cancer
  • Prostate Cancer
  • Melanoma
  • Blood Cancer
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Immune Checkpoint Inhibitors Sales Market Report 2018

1 IMMUNE CHECKPOINT INHIBITORS MARKET OVERVIEW

1.1 Product Overview and Scope of Immune Checkpoint Inhibitors
1.2 Classification of Immune Checkpoint Inhibitors by Product Category
  1.2.1 Global Immune Checkpoint Inhibitors Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Immune Checkpoint Inhibitors Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 PD-1/PD-L1
  1.2.4 CTLA-4
1.3 Global Immune Checkpoint Inhibitors Market by Application/End Users
  1.3.1 Global Immune Checkpoint Inhibitors Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Lung Cancer
  1.3.3 Colorectal Cancer
  1.3.4 Breast Cancer
  1.3.5 Prostate Cancer
  1.3.6 Melanoma
  1.3.7 Blood Cancer
  1.3.8 Other
1.4 Global Immune Checkpoint Inhibitors Market by Region
  1.4.1 Global Immune Checkpoint Inhibitors Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Immune Checkpoint Inhibitors Status and Prospect (2013-2025)
  1.4.3 China Immune Checkpoint Inhibitors Status and Prospect (2013-2025)
  1.4.4 Europe Immune Checkpoint Inhibitors Status and Prospect (2013-2025)
  1.4.5 Japan Immune Checkpoint Inhibitors Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Immune Checkpoint Inhibitors Status and Prospect (2013-2025)
  1.4.7 India Immune Checkpoint Inhibitors Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Immune Checkpoint Inhibitors (2013-2025)
  1.5.1 Global Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2025)
  1.5.2 Global Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2025)

2 GLOBAL IMMUNE CHECKPOINT INHIBITORS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Immune Checkpoint Inhibitors Market Competition by Players/Suppliers
  2.1.1 Global Immune Checkpoint Inhibitors Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Immune Checkpoint Inhibitors Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Immune Checkpoint Inhibitors (Volume and Value) by Type
  2.2.1 Global Immune Checkpoint Inhibitors Sales and Market Share by Type (2013-2018)
  2.2.2 Global Immune Checkpoint Inhibitors Revenue and Market Share by Type (2013-2018)
2.3 Global Immune Checkpoint Inhibitors (Volume and Value) by Region
  2.3.1 Global Immune Checkpoint Inhibitors Sales and Market Share by Region (2013-2018)
  2.3.2 Global Immune Checkpoint Inhibitors Revenue and Market Share by Region (2013-2018)
2.4 Global Immune Checkpoint Inhibitors (Volume) by Application

3 UNITED STATES IMMUNE CHECKPOINT INHIBITORS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Immune Checkpoint Inhibitors Sales and Value (2013-2018)
  3.1.1 United States Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018)
  3.1.2 United States Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018)
  3.1.3 United States Immune Checkpoint Inhibitors Sales Price Trend (2013-2018)
3.2 United States Immune Checkpoint Inhibitors Sales Volume and Market Share by Players (2013-2018)
3.3 United States Immune Checkpoint Inhibitors Sales Volume and Market Share by Type (2013-2018)
3.4 United States Immune Checkpoint Inhibitors Sales Volume and Market Share by Application (2013-2018)

4 CHINA IMMUNE CHECKPOINT INHIBITORS (VOLUME, VALUE AND SALES PRICE)

4.1 China Immune Checkpoint Inhibitors Sales and Value (2013-2018)
  4.1.1 China Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018)
  4.1.2 China Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018)
  4.1.3 China Immune Checkpoint Inhibitors Sales Price Trend (2013-2018)
4.2 China Immune Checkpoint Inhibitors Sales Volume and Market Share by Players (2013-2018)
4.3 China Immune Checkpoint Inhibitors Sales Volume and Market Share by Type (2013-2018)
4.4 China Immune Checkpoint Inhibitors Sales Volume and Market Share by Application (2013-2018)

5 EUROPE IMMUNE CHECKPOINT INHIBITORS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Immune Checkpoint Inhibitors Sales and Value (2013-2018)
  5.1.1 Europe Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018)
  5.1.2 Europe Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018)
  5.1.3 Europe Immune Checkpoint Inhibitors Sales Price Trend (2013-2018)
5.2 Europe Immune Checkpoint Inhibitors Sales Volume and Market Share by Players (2013-2018)
5.3 Europe Immune Checkpoint Inhibitors Sales Volume and Market Share by Type (2013-2018)
5.4 Europe Immune Checkpoint Inhibitors Sales Volume and Market Share by Application (2013-2018)

6 JAPAN IMMUNE CHECKPOINT INHIBITORS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Immune Checkpoint Inhibitors Sales and Value (2013-2018)
  6.1.1 Japan Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018)
  6.1.2 Japan Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Immune Checkpoint Inhibitors Sales Price Trend (2013-2018)
6.2 Japan Immune Checkpoint Inhibitors Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Immune Checkpoint Inhibitors Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Immune Checkpoint Inhibitors Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA IMMUNE CHECKPOINT INHIBITORS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Immune Checkpoint Inhibitors Sales and Value (2013-2018)
  7.1.1 Southeast Asia Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Immune Checkpoint Inhibitors Sales Price Trend (2013-2018)
7.2 Southeast Asia Immune Checkpoint Inhibitors Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Immune Checkpoint Inhibitors Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Immune Checkpoint Inhibitors Sales Volume and Market Share by Application (2013-2018)

8 INDIA IMMUNE CHECKPOINT INHIBITORS (VOLUME, VALUE AND SALES PRICE)

8.1 India Immune Checkpoint Inhibitors Sales and Value (2013-2018)
  8.1.1 India Immune Checkpoint Inhibitors Sales and Growth Rate (2013-2018)
  8.1.2 India Immune Checkpoint Inhibitors Revenue and Growth Rate (2013-2018)
  8.1.3 India Immune Checkpoint Inhibitors Sales Price Trend (2013-2018)
8.2 India Immune Checkpoint Inhibitors Sales Volume and Market Share by Players (2013-2018)
8.3 India Immune Checkpoint Inhibitors Sales Volume and Market Share by Type (2013-2018)
8.4 India Immune Checkpoint Inhibitors Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL IMMUNE CHECKPOINT INHIBITORS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Bristol Myer Squibb
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Bristol Myer Squibb Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 AstraZeneca
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 AstraZeneca Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 Merck & Co.
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Merck & Co. Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview
9.4 Roche / Genentech
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Roche / Genentech Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  9.4.4 Main Business/Business Overview
9.5 Incyte Corporation
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Incyte Corporation Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  9.5.4 Main Business/Business Overview
9.6 NewLink Genetics
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 NewLink Genetics Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  9.6.4 Main Business/Business Overview
9.7 ArGEN-X
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 ArGEN-X Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  9.7.4 Main Business/Business Overview
9.8 Seattle Genetics
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Seattle Genetics Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  9.8.4 Main Business/Business Overview
9.9 Pfizer
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 Pfizer Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  9.9.4 Main Business/Business Overview
9.10 MacroGenics
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Immune Checkpoint Inhibitors Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 MacroGenics Immune Checkpoint Inhibitors Sales, Revenue, Price and Gross Margin (2013-2018)
  9.10.4 Main Business/Business Overview
9.11 Celldex Therapeutics
9.12 CureTech
9.13 Immutep
9.14 Innate Pharma
9.15 Sorrento Therapeutics
9.16 GlaxoSmithKline
9.17 GITR, Inc

10 IMMUNE CHECKPOINT INHIBITORS MAUFACTURING COST ANALYSIS

10.1 Immune Checkpoint Inhibitors Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Immune Checkpoint Inhibitors
10.3 Manufacturing Process Analysis of Immune Checkpoint Inhibitors

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Immune Checkpoint Inhibitors Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Immune Checkpoint Inhibitors Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL IMMUNE CHECKPOINT INHIBITORS MARKET FORECAST (2018-2025)

14.1 Global Immune Checkpoint Inhibitors Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Immune Checkpoint Inhibitors Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Immune Checkpoint Inhibitors Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Immune Checkpoint Inhibitors Price and Trend Forecast (2018-2025)
14.2 Global Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Immune Checkpoint Inhibitors Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Immune Checkpoint Inhibitors Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 China Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 Europe Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Immune Checkpoint Inhibitors Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Immune Checkpoint Inhibitors Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Immune Checkpoint Inhibitors Sales Forecast by Type (2018-2025)
  14.3.2 Global Immune Checkpoint Inhibitors Revenue Forecast by Type (2018-2025)
  14.3.3 Global Immune Checkpoint Inhibitors Price Forecast by Type (2018-2025)
14.4 Global Immune Checkpoint Inhibitors Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Immune Checkpoint Inhibitors
Figure Global Immune Checkpoint Inhibitors Sales Volume Comparison (K Pcs) by Type (2013-2025)
Figure Global Immune Checkpoint Inhibitors Sales Volume Market Share by Type (Product Category) in 2017
Figure PD-1/PD-L1 Product Picture
Figure CTLA-4 Product Picture
Figure Global Immune Checkpoint Inhibitors Sales Comparison (K Pcs) by Application (2013-2025)
Figure Global Sales Market Share of Immune Checkpoint Inhibitors by Application in 2017
Figure Lung Cancer Examples
Table Key Downstream Customer in Lung Cancer
Figure Colorectal Cancer Examples
Table Key Downstream Customer in Colorectal Cancer
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Prostate Cancer Examples
Table Key Downstream Customer in Prostate Cancer
Figure Melanoma Examples
Table Key Downstream Customer in Melanoma
Figure Blood Cancer Examples
Table Key Downstream Customer in Blood Cancer
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Immune Checkpoint Inhibitors Market Size (Million USD) by Regions (2013-2025)
Figure United States Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Global Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Immune Checkpoint Inhibitors Sales Volume (K Pcs) (2013-2018)
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Global Immune Checkpoint Inhibitors Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Immune Checkpoint Inhibitors Sales Share by Players/Suppliers
Figure 2017 Immune Checkpoint Inhibitors Sales Share by Players/Suppliers
Figure Global Immune Checkpoint Inhibitors Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Immune Checkpoint Inhibitors Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Immune Checkpoint Inhibitors Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Immune Checkpoint Inhibitors Revenue Share by Players
Table 2017 Global Immune Checkpoint Inhibitors Revenue Share by Players
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) and Market Share by Type (2013-2018)
Table Global Immune Checkpoint Inhibitors Sales Share (K Pcs) by Type (2013-2018)
Figure Sales Market Share of Immune Checkpoint Inhibitors by Type (2013-2018)
Figure Global Immune Checkpoint Inhibitors Sales Growth Rate by Type (2013-2018)
Table Global Immune Checkpoint Inhibitors Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Immune Checkpoint Inhibitors Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Immune Checkpoint Inhibitors by Type (2013-2018)
Figure Global Immune Checkpoint Inhibitors Revenue Growth Rate by Type (2013-2018)
Table Global Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Global Immune Checkpoint Inhibitors Sales Share by Region (2013-2018)
Figure Sales Market Share of Immune Checkpoint Inhibitors by Region (2013-2018)
Figure Global Immune Checkpoint Inhibitors Sales Growth Rate by Region in 2017
Table Global Immune Checkpoint Inhibitors Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Immune Checkpoint Inhibitors Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Immune Checkpoint Inhibitors by Region (2013-2018)
Figure Global Immune Checkpoint Inhibitors Revenue Growth Rate by Region in 2017
Table Global Immune Checkpoint Inhibitors Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Immune Checkpoint Inhibitors Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Immune Checkpoint Inhibitors by Region (2013-2018)
Figure Global Immune Checkpoint Inhibitors Revenue Market Share by Region in 2017
Table Global Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Global Immune Checkpoint Inhibitors Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Immune Checkpoint Inhibitors by Application (2013-2018)
Figure Global Immune Checkpoint Inhibitors Sales Market Share by Application (2013-2018)
Figure United States Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (2013-2018)
Figure United States Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Immune Checkpoint Inhibitors Sales Price (USD/Pcs) Trend (2013-2018)
Table United States Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Players (2013-2018)
Table United States Immune Checkpoint Inhibitors Sales Volume Market Share by Players (2013-2018)
Figure United States Immune Checkpoint Inhibitors Sales Volume Market Share by Players in 2017
Table United States Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Type (2013-2018)
Table United States Immune Checkpoint Inhibitors Sales Volume Market Share by Type (2013-2018)
Figure United States Immune Checkpoint Inhibitors Sales Volume Market Share by Type in 2017
Table United States Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Application (2013-2018)
Table United States Immune Checkpoint Inhibitors Sales Volume Market Share by Application (2013-2018)
Figure United States Immune Checkpoint Inhibitors Sales Volume Market Share by Application in 2017
Figure China Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Immune Checkpoint Inhibitors Sales Price (USD/Pcs) Trend (2013-2018)
Table China Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Players (2013-2018)
Table China Immune Checkpoint Inhibitors Sales Volume Market Share by Players (2013-2018)
Figure China Immune Checkpoint Inhibitors Sales Volume Market Share by Players in 2017
Table China Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Type (2013-2018)
Table China Immune Checkpoint Inhibitors Sales Volume Market Share by Type (2013-2018)
Figure China Immune Checkpoint Inhibitors Sales Volume Market Share by Type in 2017
Table China Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Application (2013-2018)
Table China Immune Checkpoint Inhibitors Sales Volume Market Share by Application (2013-2018)
Figure China Immune Checkpoint Inhibitors Sales Volume Market Share by Application in 2017
Figure Europe Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Immune Checkpoint Inhibitors Sales Price (USD/Pcs) Trend (2013-2018)
Table Europe Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Players (2013-2018)
Table Europe Immune Checkpoint Inhibitors Sales Volume Market Share by Players (2013-2018)
Figure Europe Immune Checkpoint Inhibitors Sales Volume Market Share by Players in 2017
Table Europe Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Type (2013-2018)
Table Europe Immune Checkpoint Inhibitors Sales Volume Market Share by Type (2013-2018)
Figure Europe Immune Checkpoint Inhibitors Sales Volume Market Share by Type in 2017
Table Europe Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Application (2013-2018)
Table Europe Immune Checkpoint Inhibitors Sales Volume Market Share by Application (2013-2018)
Figure Europe Immune Checkpoint Inhibitors Sales Volume Market Share by Application in 2017
Figure Japan Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Immune Checkpoint Inhibitors Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Players (2013-2018)
Table Japan Immune Checkpoint Inhibitors Sales Volume Market Share by Players (2013-2018)
Figure Japan Immune Checkpoint Inhibitors Sales Volume Market Share by Players in 2017
Table Japan Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Immune Checkpoint Inhibitors Sales Volume Market Share by Type (2013-2018)
Figure Japan Immune Checkpoint Inhibitors Sales Volume Market Share by Type in 2017
Table Japan Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Application (2013-2018)
Table Japan Immune Checkpoint Inhibitors Sales Volume Market Share by Application (2013-2018)
Figure Japan Immune Checkpoint Inhibitors Sales Volume Market Share by Application in 2017
Figure Southeast Asia Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Immune Checkpoint Inhibitors Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Players (2013-2018)
Table Southeast Asia Immune Checkpoint Inhibitors Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Immune Checkpoint Inhibitors Sales Volume Market Share by Players in 2017
Table Southeast Asia Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Immune Checkpoint Inhibitors Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Immune Checkpoint Inhibitors Sales Volume Market Share by Type in 2017
Table Southeast Asia Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Application (2013-2018)
Table Southeast Asia Immune Checkpoint Inhibitors Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Immune Checkpoint Inhibitors Sales Volume Market Share by Application in 2017
Figure India Immune Checkpoint Inhibitors Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Immune Checkpoint Inhibitors Sales Price (USD/Pcs) Trend (2013-2018)
Table India Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Players (2013-2018)
Table India Immune Checkpoint Inhibitors Sales Volume Market Share by Players (2013-2018)
Figure India Immune Checkpoint Inhibitors Sales Volume Market Share by Players in 2017
Table India Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Type (2013-2018)
Table India Immune Checkpoint Inhibitors Sales Volume Market Share by Type (2013-2018)
Figure India Immune Checkpoint Inhibitors Sales Volume Market Share by Type in 2017
Table India Immune Checkpoint Inhibitors Sales Volume (K Pcs) by Application (2013-2018)
Table India Immune Checkpoint Inhibitors Sales Volume Market Share by Application (2013-2018)
Figure India Immune Checkpoint Inhibitors Sales Volume Market Share by Application in 2017
Table Bristol Myer Squibb Basic Information List
Table Bristol Myer Squibb Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Bristol Myer Squibb Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure Bristol Myer Squibb Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018)
Figure Bristol Myer Squibb Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table AstraZeneca Basic Information List
Table AstraZeneca Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AstraZeneca Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure AstraZeneca Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018)
Figure AstraZeneca Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table Merck & Co. Basic Information List
Table Merck & Co. Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck & Co. Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure Merck & Co. Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018
Figure Merck & Co. Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table Roche / Genentech Basic Information List
Table Roche / Genentech Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Roche / Genentech Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure Roche / Genentech Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018)
Figure Roche / Genentech Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table Incyte Corporation Basic Information List
Table Incyte Corporation Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Incyte Corporation Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure Incyte Corporation Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018)
Figure Incyte Corporation Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table NewLink Genetics Basic Information List
Table NewLink Genetics Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure NewLink Genetics Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure NewLink Genetics Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018
Figure NewLink Genetics Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table ArGEN-X Basic Information List
Table ArGEN-X Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure ArGEN-X Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure ArGEN-X Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018)
Figure ArGEN-X Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Seattle Genetics Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure Seattle Genetics Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018
Figure Seattle Genetics Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pfizer Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure Pfizer Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018)
Figure Pfizer Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table MacroGenics Basic Information List
Table MacroGenics Immune Checkpoint Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure MacroGenics Immune Checkpoint Inhibitors Sales Growth Rate (2013-2018)
Figure MacroGenics Immune Checkpoint Inhibitors Sales Global Market Share (2013-2018)
Figure MacroGenics Immune Checkpoint Inhibitors Revenue Global Market Share (2013-2018)
Table Celldex Therapeutics Basic Information List
Table CureTech Basic Information List
Table Immutep Basic Information List
Table Innate Pharma Basic Information List
Table Sorrento Therapeutics Basic Information List
Table GlaxoSmithKline Basic Information List
Table GITR, Inc Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Immune Checkpoint Inhibitors
Figure Manufacturing Process Analysis of Immune Checkpoint Inhibitors
Figure Immune Checkpoint Inhibitors Industrial Chain Analysis
Table Raw Materials Sources of Immune Checkpoint Inhibitors Major Players in 2017
Table Major Buyers of Immune Checkpoint Inhibitors
Table Distributors/Traders List
Figure Global Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Immune Checkpoint Inhibitors Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Global Immune Checkpoint Inhibitors Sales Volume (K Pcs) Forecast by Regions (2018-2025)
Figure Global Immune Checkpoint Inhibitors Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Immune Checkpoint Inhibitors Sales Volume Market Share Forecast by Regions in 2025
Table Global Immune Checkpoint Inhibitors Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Immune Checkpoint Inhibitors Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Immune Checkpoint Inhibitors Revenue Market Share Forecast by Regions in 2025
Figure United States Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Immune Checkpoint Inhibitors Revenue and Growth Rate Forecast (2018-2025)
Figure Europe Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Immune Checkpoint Inhibitors Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Immune Checkpoint Inhibitors Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) Forecast by Type (2018-2025)
Figure Global Immune Checkpoint Inhibitors Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Immune Checkpoint Inhibitors Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Immune Checkpoint Inhibitors Revenue Market Share Forecast by Type (2018-2025)
Table Global Immune Checkpoint Inhibitors Price (USD/Pcs) Forecast by Type (2018-2025)
Table Global Immune Checkpoint Inhibitors Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Immune Checkpoint Inhibitors Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories